Astellas Pharma GmbH divests German and Austrian assets


Jones Day has advised Astellas Pharma GmbH in its divestiture of certain German and Austrian Rx and OTC product assets.

Jones Day advised Astellas Pharma GmbH on the deal with a team led by partners Christian Fulda and Stefan Schneider (picture).

Involved fees earner: Stefan Schneider – Jones Day; Christian Fulda – Jones Day;

Law Firms: Jones Day;

Clients: Astellas Pharma Inc.;